Ensign Peak Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-16,766
| Closed | -$352K | – | 1912 |
|
|
2022
Q3 | $352K | Sell |
16,766
-1,110
| -6% | -$23.3K | ﹤0.01% | 1634 |
|
|
2022
Q2 | $555K | Hold |
17,876
| – | – | ﹤0.01% | 1417 |
|
|
2022
Q1 | $734K | Hold |
17,876
| – | – | ﹤0.01% | 1373 |
|
|
2021
Q4 | $777K | Sell |
17,876
-19,960
| -53% | -$868K | ﹤0.01% | 1407 |
|
|
2021
Q3 | $1.89M | Hold |
37,836
| – | – | ﹤0.01% | 1161 |
|
|
2021
Q2 | $2.38M | Sell |
37,836
-11,896
| -24% | -$749K | ﹤0.01% | 1020 |
|
|
2021
Q1 | $4.62M | Sell |
49,732
-6,057
| -11% | -$563K | 0.01% | 655 |
|
|
2020
Q4 | $5M | Buy |
55,789
+2,031
| +4% | +$182K | 0.01% | 607 |
|
|
2020
Q3 | $5.56M | Buy |
53,758
+15,922
| +42% | +$1.65M | 0.01% | 593 |
|
|
2020
Q2 | $2.99M | Hold |
37,836
| – | – | 0.01% | 776 |
|
|
2020
Q1 | $2.19M | Buy |
37,836
+2,800
| +8% | +$162K | 0.01% | 792 |
|
|
2019
Q4 | $1.89M | Buy |
+35,036
| New | +$1.89M | 0.01% | 1092 |
|